Fingerprint
Dive into the research topics of 'Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically